ζ-Crystallin displays strong selectivity for salicylic acid over aspirin
Interaction of camel lens ζ-crystallin with aspirin was investigated by activity and fluorescence measurements. Aspirin minimally inhibited the oxidoreductase activity of the enzyme and weakly quenched its fluorescence. However, significant fluorescence quenching of ζ-crystallin coincided with the a...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 293; no. 1; pp. 440 - 445 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
26.04.2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Interaction of camel lens ζ-crystallin with aspirin was investigated by activity and fluorescence measurements. Aspirin minimally inhibited the oxidoreductase activity of the enzyme and weakly quenched its fluorescence. However, significant fluorescence quenching of ζ-crystallin coincided with the appearance of a fluorescence signal characteristic of salicylic acid thereby raising the possibility that salicylic acid might have been the moiety responsible for inhibition and fluorescence quenching. Direct fluorescence measurements showed that ζ-crystallin had a much higher affinity for salicylic acid than aspirin (
K
i of about
24
μM
for salicylic acid versus
630
μM
for aspirin). Salicylic acid was also far more effective in inhibiting ζ-crystallin than aspirin (
K
i values were
23
μM
versus
820
μM
, respectively). Inhibition kinetics suggested that salicylic acid interacted with ζ-crystallin via a binding site that was distinct from that of NADPH. Salicylic acid also interacted with and quenched the fluorescence of camel lens α-crystallin suggesting a general mode of interaction with lens proteins. Within the normal therapeutic concentrations of salicylic acid or aspirin, only crystallin–salicylic acid interactions might be significant. These results showed that camel lens ζ- and α-crystallin exhibited remarkable selectivity for salicylic acid over aspirin, and thus, could be considered as salicylate-binding proteins. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0006-291X 1090-2104 |
DOI: | 10.1016/S0006-291X(02)00248-6 |